Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (DE:4NE1)
FRANKFURT:4NE1
Holding DE:4NE1?
Track your performance easily
4NE1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.82 - €13.60
Previous Close€3.16
Volume0.00
Average Volume (3M)300.00
Market Cap
€268.71M
Enterprise Value€272.98M
Total Cash (Recent Filing)$234.35M
Total Debt (Recent Filing)$238.81M
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding80,537,080
10 Day Avg. Volume30
30 Day Avg. Volume300
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)16.90
P/FCF Ratio22.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit1.42
Enterprise Value/Ebitda-8.39
Forecast
1Y Price Target
€6.83Price Target Upside116.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Accolade News
Bulls Say, Bears Say
Bulls Say
Business StrategyAccolade's diversified platform, partner ecosystem, and distribution channels should provide some resiliency as customers increasingly focus on managing costs from GLP-1s, cancer, and other items that reflect the complex nature of healthcare benefits.
Financial PerformanceThe strength in profitability, building cash flow, and robust new business pipeline development were the clear highlights for the quarter.
Market PositionACCD highlighted strong selling season dynamics, including strength across each of its channels, with particular demand for EMO/VPC with health plans.
Bears Say
Debt And Cash BalanceAccolade's net cash balance of approximately $20 million is likely too small to avoid a follow-on debt offering as its current convertible is due in April 2026.
Profitability And Marketing SpendManagement chose to proactively derisk its profitability targets by reducing marketing spend allocated to usage-based revenues, which ultimately led to a lower FY25 topline outlook.
Revenue GuidanceShares have not recovered from the significant decline following the 1Q report when the company revised down FY'25 revenue guidance.
---
4NE1 FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was €2.82 and its highest was €13.60 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Apr 24, 2025 which is in 123 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Oct 08, 2024. The company reported -€0.286 earnings per share for the quarter, beating the consensus estimate of -€0.422 by €0.136.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Accolade have?
Accolade has 80,537,080 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -€0.286 in its last earnings report, beating expectations of -€0.422. Following the earnings report the stock price went up 8.284%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 21M.
---
Accolade Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.83 (116.18% Upside)
€6.83 (116.18% Upside)
Blogger Sentiment
Bullish
DE:4NE1 Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.83%
12-Months-Change
Fundamentals
Return on Equity
-18.61%
Trailing 12-Months
Asset Growth
-11.50%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
4NE1 Company Deck
---
4NE1 Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Accolade reported strong revenue and cash flow performance, with significant new wins and a robust cash position. However, challenges include potential delays in health plan deployments and increased pressure from ROI guarantees.Read More>---
4NE1 Stock 12 Month Forecast
Average Price Target
€6.83
▲(116.18% Upside)
Technical Analysis
Best Analysts Covering 4NE1
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-22.41%
reiterated a buy rating 3 months ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -22.41% per trade.
---